Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Ozone therapy might improve cancer treatment and reduce its side effects.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Taxol damages hair growth cells, causing hair loss.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.

A new system was created to classify skin changes in cancer patients based on their treatment.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

New treatments for hair loss are being developed using molecular biology.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.